Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Apollo Endosurgery, Inc. to Host Investor Meetings at Craig-Hallum Alpha Select Conference


Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will host investor meetings at the 10th Annual Craig-Hallum Alpha Select Conference. The conference will be held Tuesday, November 12, 2019 at the Sheraton Times Square Hotel in New York City.

Investors interested in scheduling a meeting should contact their Craig-Hallum sales representative or Apollo Endosurgery investor relations at [email protected].

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today and include the OverStitchtm Endoscopic Suturing System, the OverStitch Sxtm Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.


These press releases may also interest you

at 09:35
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announces that the company will be utilizing...

at 09:30
Athletico Physical Therapy has opened a new location in Grand Blanc, Michigan, located across from Kroger and next to Starbucks on S. Saginaw Rd. This location offers convenient hours, including early morning, late evening and Saturday appointments,...

at 09:27
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the...

at 09:25
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to...

at 09:22
A unique online platform, My Yoga Journey, has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms....

at 09:20
RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software solutions for cancer radiation therapy, today announced a licensing agreement to incorporate Limbus' automated contouring software, Limbus Contour,...



News published on and distributed by: